Table 1.
Mean Measured Impedance between 6 and 9 months | ||||
---|---|---|---|---|
Group L | Group M | Group H | ||
27 – 65 Ω | 66 – 72 Ω | 73 – 170 Ω | ||
(n=48709) | (n=46933) | (n=50596) | ||
Age at implant, years | 70 ± 12 | 68 ± 11 | 65 ± 11 | p < 0.001 |
Gender | ||||
Female | 29% | 22% | 24% | |
Male | 71% | 78% | 76% | p < 0.001 |
Device type | ||||
ICD-VR | 12% | 14% | 18% | |
ICD-DR | 38% | 41% | 41% | |
CRT-D | 50% | 45% | 41% | p < 0.001 |
Mean follow-up, months | 26 ± 18 | 29 ± 19 | 32 ± 20 | p < 0.001 |
Status | ||||
Alive | 82% | 86% | 87% | |
Dead | 18% | 14% | 13% | p < 0.001 |
Abbreviations: Ω = Impedance in ohms, group L = patients with baseline measured impedance ≤ 65 ohms, Group M = patients with baseline measured impedance 66–72 ohms; Group H: patients with baseline measured impedance ≥ 73 ohms. ICD-VR = single chamber intra-cardiac defibrillator, ICD-DR = dual chamber intra-cardiac defibrillator, CRT-D = cardiac resynchronization with an cardiac defibrillator.